Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.
about
Controlling the HIV/AIDS epidemic: current status and global challengesB cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primatesGenetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodiesImpact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail.Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection.An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice.Antibody-based HIV-1 vaccines: recent developments and future directions.
P2860
Q30420558-2E23BDA0-41A5-4912-A7D9-ABBD153674CCQ33373664-AA6CABE0-031E-4C48-9D12-D52BCB4245A0Q33614605-CFD75C76-C6F9-49B7-BB9B-BE51FD0EC10AQ33719511-673BEFA7-64E2-48BB-BF28-C43BFD20F58EQ34392963-76428879-C7A1-420E-8887-2503B82A0D26Q34593647-04C9D25A-FB5C-4ADE-B4CB-8CF7DD09F9A5Q36377601-85582798-D61E-46DC-9637-0842A5B2ADBCQ37051575-480ADEB1-D8EB-4881-8945-EE57F2198DB7Q37311315-F4B72736-B792-4DF9-AFD0-95E0221BFEEDQ39300864-429F42FB-E539-4B25-84D9-6A7FFA267C64Q42217775-56803EB5-E5A1-4F3E-B5B7-0B86BEAA128FQ42738983-6CFB4C7A-F07F-4201-8CE8-CA73A407C87A
P2860
Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@ast
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@en
type
label
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@ast
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@en
prefLabel
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@ast
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@en
P2093
P2860
P1433
P1476
Vaccine-delivered HIV envelope ...... or poor HIV vaccine responses.
@en
P2093
Drew Weissman
Houping Ni
James A Hoxie
Kathy Fernando
P2860
P304
P356
10.1182/BLOOD-2006-08-038661
P407
P577
2006-12-07T00:00:00Z